Major Scope

  •  Lung Cancer
  •  Colorectal Cancer
  •  Pancreatic Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Liver Cancer
  •  Leukemia
  •  Bladder Cancer
  •  Kidney Cancer
  •  Endometrial Cancer
  •  Oncology Case Reports
  •  Radiation Therapy

Abstract

Citation: Clin Oncol. 2020;5(1):1750.DOI: 10.25107/2474-1663-v5-id1750

Regional Recurrence of Breast Cancer in Ipsilateral Intramammary Lymph Node Six Months after Breast Conserving Surgery

Xiaoling Liu, Zijian Yang, Guangxin Li, Sameh Yousef and Wei Wei

Department of Breast and Thyroid Surgery, Peking University Shenzhen Hospital, China
Department of Surgery, Yale University School of Medicine, USA

*Correspondance to: Xiaoling Liu 

 PDF  Full Text Case Report | Open Access

Abstract:

A 40-year-old female was diagnosed with left breast ductal carcinoma in-situ by Core Needle Biopsy (CNB) and underwent breast conserving surgery and sentinel lymph node biopsy. Final pathology reported invasive carcinoma, no special type, grade III, triple negative subtype. She started postoperative chemotherapy 2 weeks after surgery and received 4 cycles of epirubicin plus
Cyclophosphamide, followed by 2 cycles of Docetaxel. The sixth chemo cycle was postponed for more than one month because of the outbreak of COVID-19. After her sixth cycle of chemotherapy, she underwent breast ultrasound and was found to have a new lesion in the ipsilateral breast. Vacuumassisted biopsy of the lesion confirmed recurrence of breast cancer in an Intramammary Lymph Node (IMLN) and she underwent completion mastectomy. Chemotherapy regimen was changed to Vinorelbine in combination with Capecitabine due to primary resistance to anthracyclines and Docetaxel. Radiotherapy was also arranged for her.

Keywords:

Breast cancer; Breast conserving surgery; Recurrence; Intramammary lymph node; Sentinel lymph node

Cite the Article:

Liu X, Yang Z, Li G, Yousef S, Wei W. Regional Recurrence of Breast Cancer in Ipsilateral Intramammary Lymph Node Six Months after Breast Conserving Surgery. Clin Oncol. 2020;5:1750..

Journal Basic Info

  • Impact Factor: 3.231**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
  • PubMed NLM ID: 101705590

Search Our Journal

Journal Indexed In

Articles in PubMed

Metastatic Retroperitoneal Paraganglioma: Case Report and Review of the Literature
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Research Progress on the Origin and Mechanism of Liver Cancer Stem Cells
 Abstract  PDF  Full Text
Regional Recurrence of Breast Cancer in Ipsilateral Intramammary Lymph Node Six Months after Breast Conserving Surgery
 Abstract  PDF  Full Text
View More...